During the past decade, Sichuan Provincial People's Hospital conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 6 clinical trials were completed, i.e. on average, 8.8% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 4 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sichuan Provincial People's Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "BeiGene" with 5 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Sichuan Provincial People's Hospital" with 4 trials sponsored and "Sunshine Lake Pharma Co., Ltd." with 4 trials sponsored. Other sponsors include 64 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sichuan Provincial People's Hospital" #1 collaborator was "Sichuan Provincial People's Hospital" with 13 trials as a collaborator, "West China Hospital" with 6 trials as a collaborator, "The First Affiliated Hospital of Zhengzhou University" with 4 trials as a collaborator, "Beijing Hospital" with 3 trials as a collaborator and "Central South University" with 3 trials as a collaborator. Other collaborators include 272 different institutions and companies that were collaborators in the rest 235 trials.

According to Clinical.Site data, the most researched conditions in "Sichuan Provincial People's Hospital" are "Alzheimer Disease" (2 trials), "Anesthesia" (2 trials), "Breast Neoplasms" (2 trials), "Chronic Heart Failure" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Sichuan Provincial People's Hospital" in a lesser frequency.

Most popular intervention types in "Sichuan Provincial People's Hospital" are "Drug" (65 trials), "Procedure" (8 trials), "Device" (4 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Docetaxel" (5 trials), "Tislelizumab" (4 trials), "Dexamethasone" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Sichuan Provincial People's Hospital" are 80 trials for "All" genders, 6 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 45 active trials in "Sichuan Provincial People's Hospital". 3 are not yet recruiting, 31 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 35 completed trials in Sichuan Provincial People's Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sichuan Provincial People's Hospital, 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 6 trials that are defined as “Not Applicable".